Artificial intelligence tools are increasingly capable of identifying bone lesions in patients with prostate cancer and multiple myeloma, potentially streamlining the monitoring of disease progression. According to research published in …
Tag:
multiple myeloma
-
-
Teclistamab for Relapsed or Refractory Multiple Myeloma: Managing Side Effects and Long-Term Outcomes Teclistamab, marketed as TECVAYLI®, is a B-cell maturation antigen (BCMA) × CD3 bispecific antibody used to treat …
-
Common Cardio Drugs Appear Safe for Multiple Myeloma Patients Many adults diagnosed with multiple myeloma also manage cardiovascular conditions, often requiring medications for heart health. New international research offers reassuring …
-
Brazilian Doctor Achieves Complete Remission from Advanced Multiple Myeloma with CAR-T Cell Therapy A Brazilian physician, Jonathan Miranda, has experienced complete remission from advanced multiple myeloma following treatment with CAR-T …
-
Of Livia Gamondi Life expectancy has gone from two and a half years to almost ten years. Immunotherapy is changing treatment, allowing patients a good quality of life, with fewer …
-
subcutaneous Bortezomib May Reduce Adverse Effects in Multiple myeloma Subcutaneous (SC) bortezomib (Velcade; takeda Pharmaceuticals) may be associated with a lower incidence of peripheral neuropathy, infection, adn dyspepsia compared with …
-
SWIFT-seq: A New Blood Test for Multiple Myeloma SWIFT-seq, a new blood test from Dana-Farber Cancer Institute researchers, could change how multiple myeloma (MM) is diagnosed adn monitored. It offers …
-
“`html SWIFT-seq: A New Blood Test for Multiple Myeloma SWIFT-seq: A New Blood Test for multiple Myeloma Table of Contents SWIFT-seq: A New Blood Test for multiple Myeloma Understanding Multiple …
-
## The Critical Need for Interoperable Healthcare Data in Modern Oncology The escalating costs of innovative cancer therapies, such as chimeric antigen receptor (CAR) T-cell therapies and bispecific antibodies – …